The FDA gives unsalable article companies 90 days to flow up with ads that describe HIV's true toll Can ads for AIDS remedys promote unsafe sex? At first blush.

Ireland calling cards
sign up our free UK yellow pages find local business
PC Notdienst Berlin

The FDA gives unsalable article companies 90 days to flow up with ads that describe HIV's true toll

Can ads for AIDS remedys promote unsafe sex? At first blush, that would have the appearance a preposterous proposition. After all, those billboards and print ads flooding the nation's gayer quarters should remind men that the pandemic isn't going anywhere, at least any time soon

however some activists say the ads have become in the way that full of robust, healthy young men that they lead populace to think HIV is no big deal. And that, the activists say, is influencing gay men's decisions about safer sex in succession April 27, the U.S. fare and Drug Administration weighed in upon the issue, sending letters to eight remedy companies to give them 90 days to clean up their advertising act.

Several factors l to the FDA's stir including a report released April 12 by the agency of the University of California, San Francisco, which fix that 62% of 262 race surveyed in health clinics conception the ads led to condomless sex Jeff Getty of Survive AIDS admitted that the contemplation doesn't prove a connection between the ads and infection rates however noted a "confidence factor" at work: "The more someone is confident they'll survive the disease, the more likely they'll be to have unsafe sex" he said.

Richard Klein, the FDA's HIV/AIDS program director, said the study's conclusions were "a little iffy" still still enough to prompt a review. He added that the agency will have "regulatory enforcement powers" against companies that, don't comply

There might be near mild resistance among companies eager to vend their drugs in a competitive marketplace. Kyra Lindemann, spokeswoman for Merck & Co which makes the protease inhibitor Crixivan, said the ads "have been true successful in motivating patients to talk to their doctors about treatment options." Declining to explanation on the FDA letter, she added that "anecdotal reports point out people are leading more active, healthy lives as a eventuate of their treatment. They apply the mind and feel better."

...

Home